Table 5

Prognosis in treated pulmonary hypertension. Data from references 3 and 65. The historical group were studied before there was any consensus on conventional therapy

Years from diagnosis All patients: historical group survival rate (%) NYHA III and IV: conventional therapy5-150
survival rate(%)
NYHA III and IV: epoprostenol survival rate(%)
1687787
25273
3484163
430
5342754
  • 5-150 Warfarin, digoxin, diuretics